Clinical Trial Update: Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial comparing biweekly versus triweekly raltitrexed with oxaliplatin (with or without bevacizumab) as first-line treatment for metastatic colorectal c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Tomudex (ZD1694)

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED